There is a sharp increase in India's cancer cases with only 20% - 30% of cancers are being diagnosed in stages I and II.

Fortunately, PET-CT has revolutionized cancer diagnosis. However, PET-CT requires a radiopharmaceutical (FDG) to function, which is extremely short-lived and requires an expensive cyclotron. Our vision is to make FDG accessible and affordable to most of the PET-CT facilities in India.

Our Mission


Increase Affordability of FDG


Increase Accessibility of FDG

Society + Science

Create Employment + Facilitate Research